Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Glycinate vs Hydrochloride for Postprandial Lipemia in T2D
NCT02064881Phase 3Unknown
- Sponsor
- Laboratorios Silanes
- Start
- Oct 2015
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Metformin glycinate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Laboratorios Silanes. Primary endpoint: Change in postprandial lipemia (area under the curve of triglycerides) at 4 months. Status: unknown.
02
Drugs
Metformin glycinate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02064881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064881.